Semczuk W
Neurol Neurochir Pol. 1978 Nov-Dec;12(6):699-704.
The investigations were carried out in 30 control cases, in 20 patients with acute transient cerebral circulatory failure, 20 patients with intracerebral haemorrhage, and 22 patients with thrombotic encephalomalacia. The determinations of uropepsin activity were done on the 1st, 3rd, 7th and 14th days of the disease. Uropepsin activity in 24-hour urine was determined by the method of West, Ellis and Scott. In the group of patients with acute transient cerebral circulatory failure abnormalities in urinary uropepsin activity were not significant. The mean activity of uropepsin in 24-hour urine in patients with intracerebral haemorrhage and brain infarction on the 1st day of the disease was significantly higher than in controls. The rise in the activity of this enzyme in patients with encephalomalacia was lower in relation to patients with intracerebral haemorrhages. During improvement of the condition of patients with brain stroke the uropepsin activity in 24-hour urine decreased.
对30例对照病例、20例急性短暂性脑循环衰竭患者、20例脑出血患者和22例血栓性脑软化患者进行了研究。在疾病的第1天、第3天、第7天和第14天测定尿胃蛋白酶活性。采用韦斯特、埃利斯和斯科特的方法测定24小时尿液中的尿胃蛋白酶活性。急性短暂性脑循环衰竭患者组的尿胃蛋白酶活性异常不显著。脑出血和脑梗死患者在疾病第1天24小时尿液中尿胃蛋白酶的平均活性显著高于对照组。与脑出血患者相比,脑软化患者该酶活性的升高较低。在脑卒中患者病情改善期间,24小时尿液中的尿胃蛋白酶活性降低。